Product Development

Alira Health Ventures: Incubation of Breakthrough Technologies

Developing tomorrow’s breakthroughs

As one of the few life science advisory firms with an in-house incubator dedicated to breakthrough technology, our commitment to transforming healthcare extends to our portfolio companies.

Alira Health Ventures manages these wholly-owned companies, providing critical support that allows them to develop the next technology breakthrough in Pharma and Life Sciences.

Delivering viable innovations to market

If you’re looking to expand your product portfolio, you can purchase or license our technologies that are designed to advance patient care—and your bottom line. Our discoveries deliver real value to patients, clinicians, and investors.

Accelerating Innovation, Transforming Healthcare

Alira Health Ventures offers support in product portfolio expansion, technology acquisition or licensing, and more.

Contact Us
Gabriele Brambilla
Gabriele Brambilla
Chief Executive Officer
Alira Health Ventures is dedicated to nurturing innovative technologies and propelling development from concept to clinical evaluation for future commercialization.

Related news

Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
M&A
Publications February 24, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more download our latest TAD Infographic.
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
Regulatory
News February 2, 2021
We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System
We are proud to announce the firm’s Regulatory practice has secured a Breakthrough Device Designation from FDA for the real-time tissue perfusion system, PEDRA Xauron Perfusion System.
Patient Engagement
Publications January 28, 2021
Creating a Lifecycle of Patient Engagement
At Alira Health, we believe the relationship between healthcare companies and patients should be a partnership. Developing this partnership helps build trust, enhances the patient experience,(...)
Patient Engagement
News January 26, 2021
Annabel de Maria Joins Alira Health as Vice President, Patient Engagement
We are pleased to announce that Annabel de Maria has joined the firm as Vice President, Patient Engagement.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.